Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Battermann

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2004
Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment positionIvessa M Dijkema, Pieter Hofman, Cornelis P J Raaijmakers, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
BEta versus Gamma Utrecht Trial-Cypher (BEGUT-CYPHER): Is intracoronary brachytherapy still superior to drug-eluting stents?P R Stella, P de Jaegere, J J Battermann, et al.
Physics in Medicine and Biology|March 1, 1996
Dose uniformity in MECS interstitial hyperthermia: the impact of longitudinal control in model anatomiesJ F van der Koijk, J Crezee, G M van Leeuwen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2005
Quality of life of patients after permanent prostate brachytherapy in relation to dosimetryMarion P R Van Gellekom, Marinus A Moerland, Marco Van Vulpen, et al.
Brachytherapy|October 24, 2009
Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapyMaaike R Moman, Henk G van der Poel, Jan J Battermann, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2002
The mechanism of regression of solid SL2 lymphosarcoma after local IL-2 therapyAnton H C Baselmans, Jan-Willem Koten, Jan J Battermann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2012
Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patientsG Goldner, R Pötter, J J Battermann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patientsGregor Goldner, Richard Pötter, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2010
Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapyEllen M Roeloffzen, Marco van Vulpen, Jan J Battermann, et al.
Physics in Medicine and Biology|January 5, 2002
Determination and validation of the actual 3D temperature distribution during interstitial hyperthermia of prostate carcinomaB W Raaymakers, M Van Vulpen, J J Lagendijk, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2004
Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment positionIvessa M Dijkema, Pieter Hofman, Cornelis P J Raaijmakers, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
BEta versus Gamma Utrecht Trial-Cypher (BEGUT-CYPHER): Is intracoronary brachytherapy still superior to drug-eluting stents?P R Stella, P de Jaegere, J J Battermann, et al.
Physics in Medicine and Biology|March 1, 1996
Dose uniformity in MECS interstitial hyperthermia: the impact of longitudinal control in model anatomiesJ F van der Koijk, J Crezee, G M van Leeuwen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2005
Quality of life of patients after permanent prostate brachytherapy in relation to dosimetryMarion P R Van Gellekom, Marinus A Moerland, Marco Van Vulpen, et al.
Brachytherapy|October 24, 2009
Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapyMaaike R Moman, Henk G van der Poel, Jan J Battermann, et al.
Cancer Immunology, Immunotherapy : CII|October 3, 2002
The mechanism of regression of solid SL2 lymphosarcoma after local IL-2 therapyAnton H C Baselmans, Jan-Willem Koten, Jan J Battermann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2012
Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patientsG Goldner, R Pötter, J J Battermann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patientsGregor Goldner, Richard Pötter, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2010
Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapyEllen M Roeloffzen, Marco van Vulpen, Jan J Battermann, et al.
Physics in Medicine and Biology|January 5, 2002
Determination and validation of the actual 3D temperature distribution during interstitial hyperthermia of prostate carcinomaB W Raaymakers, M Van Vulpen, J J Lagendijk, et al.
Pageof 11